167 related articles for article (PubMed ID: 7731153)
1. Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia.
Perna AF; Ingrosso D; De Santo NG; Galletti P; Zappia V
Kidney Int; 1995 Jan; 47(1):247-53. PubMed ID: 7731153
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of the mechanism by which homocysteine potentiates the anti-vaccinia virus effects of the S-adenosylhomocysteine hydrolase inhibitor 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine.
Hasobe M; McKee JG; Ishii H; Cools M; Borchardt RT; De Clercq E
Mol Pharmacol; 1989 Sep; 36(3):490-6. PubMed ID: 2779528
[TBL] [Abstract][Full Text] [Related]
3. Disposition of homocysteine and S-3-deazaadenosylhomocysteine in cells exposed to 3-deazaadenosine.
Svardal A; Djurhuus R; Ueland PM
Mol Pharmacol; 1986 Aug; 30(2):154-8. PubMed ID: 3736540
[TBL] [Abstract][Full Text] [Related]
4. Decreased transmethylation of biogenic amines after in vivo elevation of brain S-adenosyl-l-homocysteine.
Schatz RA; Wilens TE; Sellinger OZ
J Neurochem; 1981 May; 36(5):1739-48. PubMed ID: 7241133
[TBL] [Abstract][Full Text] [Related]
5. Metabolic consequences of hyperhomocysteinemia in uremia.
Perna AF; Ingrosso D; Satta E; Romano M; Cimmino A; Galletti P; Zappia V; De Santo NG
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S85-90. PubMed ID: 11576929
[TBL] [Abstract][Full Text] [Related]
6. Effects of 4'-modified analogs of aristeromycin on the metabolism of S-adenosyl-L-homocysteine in murine L929 cells.
Ault-Riché DB; Lee Y; Yuan CS; Hasobe M; Wolfe MS; Borcherding DR; Borchardt RT
Mol Pharmacol; 1993 Jun; 43(6):989-97. PubMed ID: 8316227
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of transmethylation disturbs neurulation in chick embryos.
Afman LA; Blom HJ; Drittij MJ; Brouns MR; van Straaten HW
Brain Res Dev Brain Res; 2005 Aug; 158(1-2):59-65. PubMed ID: 15996755
[TBL] [Abstract][Full Text] [Related]
8. Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease.
Loehrer FM; Tschöpl M; Angst CP; Litynski P; Jäger K; Fowler B; Haefeli WE
Atherosclerosis; 2001 Jan; 154(1):147-54. PubMed ID: 11137094
[TBL] [Abstract][Full Text] [Related]
9. Effects of adenosine dialdehyde on S-adenosylhomocysteine hydrolase and S-adenosylmethionine-dependent transmethylations in mouse L929 cells.
Bartel RL; Borchardt RT
Mol Pharmacol; 1984 May; 25(3):418-24. PubMed ID: 6727864
[TBL] [Abstract][Full Text] [Related]
10. Tissue levels of S-adenosylhomocysteine in the rat kidney: effects of ischemia and homocysteine.
Kloor D; Delabar U; Mühlbauer B; Luippold G; Osswald H
Biochem Pharmacol; 2002 Feb; 63(4):809-15. PubMed ID: 11992651
[TBL] [Abstract][Full Text] [Related]
11. Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
Hasobe M; Mckee JG; Borcherding DR; Keller BT; Borchardt RT
Mol Pharmacol; 1988 Jun; 33(6):713-20. PubMed ID: 2454388
[TBL] [Abstract][Full Text] [Related]
12. Combined modulation of S-adenosylmethionine biosynthesis and S-adenosylhomocysteine metabolism enhances inhibition of nucleic acid methylation and L1210 cell growth.
Kramer DL; Porter CW; Borchardt RT; Sufrin JR
Cancer Res; 1990 Jul; 50(13):3838-42. PubMed ID: 2354436
[TBL] [Abstract][Full Text] [Related]
13. Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism.
Perna AF; Castaldo P; De Santo NG; di Carlo E; Cimmino A; Galletti P; Zappia V; Ingrosso D
Kidney Int; 2001 Jun; 59(6):2299-308. PubMed ID: 11380834
[TBL] [Abstract][Full Text] [Related]
14. Influence of S-adenosylhomocysteine hydrolase inhibitors on S-adenosylhomocysteine and S-adenosylmethionine pool levels in L929 cells.
Cools M; De Clercq E
Biochem Pharmacol; 1990 Nov; 40(10):2259-64. PubMed ID: 2244927
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis and transmethylation metabolites in HL-60 cells.
Endresen PC; Loennechen T; Kildalsen H; Aarbakke J
J Pharmacol Exp Ther; 1996 Sep; 278(3):1318-24. PubMed ID: 8819518
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine.
Perna AF; Ingrosso D; Zappia V; Galletti P; Capasso G; De Santo NG
J Clin Invest; 1993 Jun; 91(6):2497-503. PubMed ID: 8514862
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine regulates fatty acid and lipid metabolism in yeast.
Visram M; Radulovic M; Steiner S; Malanovic N; Eichmann TO; Wolinski H; Rechberger GN; Tehlivets O
J Biol Chem; 2018 Apr; 293(15):5544-5555. PubMed ID: 29414770
[No Abstract] [Full Text] [Related]
18. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease.
Castro R; Rivera I; Struys EA; Jansen EE; Ravasco P; Camilo ME; Blom HJ; Jakobs C; Tavares de Almeida I
Clin Chem; 2003 Aug; 49(8):1292-6. PubMed ID: 12881445
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine.
Stam F; van Guldener C; ter Wee PM; Kulik W; Smith DE; Jakobs C; Stehouwer CD; de Meer K
Am J Physiol Renal Physiol; 2004 Aug; 287(2):F215-23. PubMed ID: 15271686
[TBL] [Abstract][Full Text] [Related]
20. S-Adenosylhomocysteine hydrolase overexpression in HEK-293 cells: effect on intracellular adenosine levels, cell viability, and DNA methylation.
Hermes M; Osswald H; Riehle R; Piesch C; Kloor D
Cell Physiol Biochem; 2008; 22(1-4):223-36. PubMed ID: 18769049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
